ClinicalTrials.gov
ClinicalTrials.gov Menu

An Intervention to Reduce Inappropriate Prescriptions for Elderly Patients in General Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00281450
Recruitment Status : Completed
First Posted : January 24, 2006
Last Update Posted : April 28, 2010
Sponsor:
Information provided by:
University of Oslo

Brief Summary:
This study will explore the possible effect of a tailored educational intervention towards general practitioners, in order to reduce inappropriate prescription patterns for elderly patients > 70 years.

Condition or disease Intervention/treatment Phase
Aged Family Practice Behavioral: Educational intervention Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 85836 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice
Study Start Date : January 2006
Actual Primary Completion Date : March 2007
Actual Study Completion Date : March 2007

Intervention Details:
  • Behavioral: Educational intervention
    We developed a set of explicit criteria for pharmacological inappropriateness for Norwegian GPs' prescribing to elderly patients. The main purpose of the criteria was to serve as quality indicators during an educational intervention: the Prescription Peer Academic Detailing (Rx-PAD) Study, aimed at improving GPs' prescribing for elderly patients.


Primary Outcome Measures :
  1. Changes in a set of predefined quality indicators measuring appropriateness of prescriptions for elderly out-patients [ Time Frame: 1 year ]
    Prescription data for 1 year were retrospectively retrieved from the Norwegian Prescription Database (NorPD) and assessed in relation to 13 prescription quality indicators.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • General practitioner
  • Specialist in general practice

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00281450


Sponsors and Collaborators
University of Oslo
Investigators
Principal Investigator: Sture Rognstad, MD University of Oslo

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jorund Straand, professor MD PhD, University of Oslo
ClinicalTrials.gov Identifier: NCT00281450     History of Changes
Other Study ID Numbers: 850652
First Posted: January 24, 2006    Key Record Dates
Last Update Posted: April 28, 2010
Last Verified: December 2005